{ "as_of": "2026-11-06", "cmr": "uk-cm-kg/LSE/ONT", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# OXFORD NANOPORE TECHNOLOGIES PLC (LSE Main Market: ONT) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is OXFORD NANOPORE TECHNOLOGIES PLC, listed on LSE Main Market under ticker ONT, with ISIN GB00BP6S8Z30 and LEI 213800IRWQ2Q6M2CDW55. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 80 filings across 66 filing days in the twelve months to 2026-11-06. The median gap between filing days is 5 days. The latest filing is dated 2026-11-04, 2 days before the record date, and is of type regulatory_announcement. The LSE Main Market median cadence gap is 4 days across 892 issuers, with a median of 29.0 filings and a median latency of 3 days. The Pharmaceuticals and Biotechnology [201030] sector median cadence gap is 6.0 days across 51 issuers, with a median of 42 filings and a median latency of 4.0 days.\n\n## Auditor\n\nThe auditor of record is Grant Thornton UK LLP. The location of the auditor is not on the record. Auditor changes are not on the record, as the register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as the register has no lifecycle type map yet. The index does not carry a halt event, and the issuer is listed, not halted.\n\n## Orderability\n\nFor the elective professional client category, the outcome is signal ACM-200 and is determinable. For the eligible counterparty category, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read, and the count is 0.\n\n## Open research\n\nNo openly published research notes were found, and the count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No issuer years are sealed. The market has no earliest sealed date, and the live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n10 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/ONT (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/05386273 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/ONT/oxford-nanopore-technologies-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/LSE/ONT (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://nanoporetech.com/api/assets/f/196663/x/98971d7bea/ont-interim-results-for-the-six-months-ended-30-june-2026-rns.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.uk-cm-kg.ai/record/LSE/ONT (the record)\n", "market": "UK", "node": "uk-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-11", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "Tavily regex · adjudicated by Claude", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://nanoporetech.com/api/assets/f/196663/x/98971d7bea/ont-interim-results-for-the-six-months-ended-30-june-2026-rns.pdf", "state": "filled", "value": "Grant Thornton UK LLP" }, "auditor_firm_id": { "market": "UK", "state": "not_on_record" }, "auditor_location": { "market": "UK", "state": "not_on_record" }, "changes": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "cmr": "uk-cm-kg/LSE/ONT", "coverage": { "count": 0, "houses": [], "pages_checked": [], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 892, "median_cadence_gap_days": 4, "median_filings": 29, "median_latency_days": 3, "name": "LSE Main Market" }, "sector": { "issuers": 51, "median_cadence_gap_days": 6, "median_filings": 42, "median_latency_days": 4, "name": "Pharmaceuticals and Biotechnology [201030]" } }, "by_type": { "agm_record_date": 2, "ch_accounts_filed": 1, "ch_capital": 16, "ch_charge": 1, "ch_confirmation_statement": 1, "ch_officer_change": 2, "ch_resolution": 1, "corporate_action": 11, "director_dealing": 22, "early_warning": 3, "financial_statement": 5, "regulatory_announcement": 15 }, "cadence_median_gap_days": 5, "filing_days": 66, "filings": 80, "latency_days": 2, "latest": [ { "category": null, "date": "2026-11-04", "source": "https://www.investegate.co.uk/announcement/rns/oxford-nanopore-technologies--ont/participation-in-upcoming-investor-conferences/9857004", "title": "Participation in upcoming investor conferences", "type": "regulatory_announcement" }, { "category": null, "date": "2026-11-02", "source": "https://www.investegate.co.uk/announcement/rns/oxford-nanopore-technologies--ont/issue-of-equity-and-total-voting-rights/9854171", "title": "Issue of Equity and Total Voting Rights", "type": "corporate_action" }, { "category": null, "date": "2026-10-27", "source": "https://find-and-update.company-information.service.gov.uk/company/05386273/filing-history/MzU1MzA3MDM3MGFkaXF6a2N4/document?format=pdf&download=0", "title": "capital allotment shares — 2026-10-15", "type": "ch_capital" }, { "category": null, "date": "2026-10-20", "source": "https://www.investegate.co.uk/announcement/rns/oxford-nanopore-technologies--ont/appointment-of-chief-business-development-officer/9830655", "title": "Appointment of Chief Business Development Officer", "type": "director_dealing" }, { "category": null, "date": "2026-10-14", "source": "https://www.investegate.co.uk/announcement/rns/oxford-nanopore-technologies--ont/share-incentive-plan-director-pdmr-shareholding/9823233", "title": "Share Incentive Plan - Director/PDMR Shareholding", "type": "director_dealing" } ], "latest_filing_date": "2026-11-04", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.uk-cm-kg.ai/events/LSE/ONT", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "LSE Main Market" }, "isin": { "read_by": "LSE instrument reference record (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/ONT", "state": "confirmed", "value": "GB00BP6S8Z30" }, "jurisdiction": { "read_by": "Companies House REST API (company profile) (jurisdiction field)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://find-and-update.company-information.service.gov.uk/company/05386273", "state": "confirmed", "value": "England and Wales (Companies House jurisdiction field)" }, "lei": { "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN", "read_date": "2026-11-09", "read_date_basis": "the field", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00BP6S8Z30)", "state": "sourced", "value": "213800IRWQ2Q6M2CDW55" }, "name": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "OXFORD NANOPORE TECHNOLOGIES PLC" }, "sector": { "read_by": "LSE issuer profile (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/stock/ONT/oxford-nanopore-technologies-plc/company-page", "state": "sourced", "value": "Pharmaceuticals and Biotechnology [201030]" }, "security_type": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "Corporate" }, "segment": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "STMM" }, "ticker": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=MAINMARKET, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "ONT" }, "website": { "read_by": "LSE issuer profile (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/stock/ONT/oxford-nanopore-technologies-plc/company-page", "state": "sourced", "value": "www.nanoporetech.com" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "domicile_change": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "listing": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "name_change": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "segment_move": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "market": "UK", "node": "uk-cm-kg", "numbers_hash": "sha256:7ccd81ad6c2505012023513f20cba414d8e52ceb071b55f36e1863b498ac5a23", "open_research": { "read_date": "2026-11-12", "rows": [], "state": "none_found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "elective professional client", "eligible counterparty" ], "outcomes": { "elective professional client": { "determinable": true, "signal": "ACM-200" }, "eligible counterparty": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json", "door": "https://mcp.uk-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1", "section": "uk.aio.v16" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.uk-cm-kg.ai/record/LSE/ONT", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-09", "source": "https://marketsecurities.fca.org.uk/officiallist", "value": "listed, not halted" } }, "numbers_hash": "sha256:7ccd81ad6c2505012023513f20cba414d8e52ceb071b55f36e1863b498ac5a23", "path": "/uk/LSE/ONT", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is OXFORD NANOPORE TECHNOLOGIES PLC, listed on LSE Main Market under ticker ONT, with ISIN GB00BP6S8Z30 and LEI 213800IRWQ2Q6M2CDW55. Its security type is Corporate, its segment is STMM, its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 80 filings across 66 filing days in the twelve months to 2026-11-06. The median gap between filing days is 5 days. The latest filing is dated 2026-11-04, 2 days before the record date, and is of type regulatory_announcement. The LSE Main Market median cadence gap is 4 days across 892 issuers, with a median of 29.0 filings and a median latency of 3 days. The Pharmaceuticals and Biotechnology [201030] sector median cadence gap is 6.0 days across 51 issuers, with a median of 42 filings and a median latency of 4.0 days.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is Grant Thornton UK LLP. The location of the auditor is not on the record. Auditor changes are not on the record, as the register has no lifecycle type map yet.", "title": "Auditor" }, { "id": "events", "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as the register has no lifecycle type map yet. The index does not carry a halt event, and the issuer is listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "For the elective professional client category, the outcome is signal ACM-200 and is determinable. For the eligible counterparty category, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "No research houses were found on the issuer's investor-relations pages read, and the count is 0.", "title": "Coverage" }, { "id": "open_research", "text": "No openly published research notes were found, and the count is 0.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed. No issuer years are sealed. The market has no earliest sealed date, and the live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "10 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer" }, { "for": "identity.isin", "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/ONT" }, { "for": "identity.jurisdiction", "source": "https://find-and-update.company-information.service.gov.uk/company/05386273" }, { "for": "identity.lei", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download" }, { "for": "identity.sector", "source": "https://www.londonstockexchange.com/stock/ONT/oxford-nanopore-technologies-plc/company-page" }, { "for": "the disclosure lines", "source": "https://mcp.uk-cm-kg.ai/events/LSE/ONT" }, { "for": "the halt flag", "source": "https://marketsecurities.fca.org.uk/officiallist" }, { "for": "the auditor", "source": "https://nanoporetech.com/api/assets/f/196663/x/98971d7bea/ont-interim-results-for-the-six-months-ended-30-june-2026-rns.pdf" }, { "for": "the orderability chapter", "source": "https://mcp.uk-cm-kg.ai/book/aio.json" }, { "for": "the record", "source": "https://mcp.uk-cm-kg.ai/record/LSE/ONT" } ], "title": "OXFORD NANOPORE TECHNOLOGIES PLC (ONT) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }